New Study Details Unique Treatment for Pancreatic Cancer

Jan. 20, 2013 - PRLog -- In 2010, about 43,140 people were diagnosed with pancreatic cancer, according to the American Cancer Society; 36,800 died. According to an article on WebMD that discusses a new study on Pancreatic Cancer and treatment, “A novel approach to pancreatic cancer treatment that activates the immune system works in some patients.”

The Center for the Biology of Chronic Disease (CBCD) is very encouraged by studies like these which show improvement in the survival of cancer patients.

Researcher Robert H. Vonderheide, MD, DPhil, an associate professor of medicine in the division of hematology/oncology and the Abramson Family Cancer Research Institute, University of Pennsylvania said, “The therapy is an antibody. Instead of binding to the cancer, this antibody binds to a molecule in the immune system, and that is CD40. Next, the immune system is activated, allowing it to attack the so-called scaffolding around the cancer cells. The scaffolding is destroyed and the tumor falls apart. The process is somewhat like attacking a brick wall by dissolving the mortar in the wall.”

The new approach extended overall survival by nearly two months compared to conventional treatments.

Another study discussed in the scientific journal Acta Oncologica, showed how treatment with the natural antiviral supplement Gene-Eden-VIR caused a complete recovery of the immune system and an amazing 34% reduction in tumor size in a patient with pancreatic cancer. The study was conducted at the Center for the Biology of Chronic Disease by Hanan Polansky and Ido Dafni,

Acta Oncologica is a leading scientific journal in clinical oncology and related disciplines, and the official journal of the five Nordic oncological societies.

The CBCD has long advocated the need for people to maintain a healthy immune system. The immune system is key in the body’s defense against many different chronic diseases, including cancers such as pancreatic cancer.

According to the WebMD website:

“If you’re among the 1.5 million people in the United States diagnosed with cancer each year, you may be considering taking vitamins and supplements for cancer. Supplements, herbs, and extracts are increasingly used in integrative medicine to:

Help strengthen the immune system
Help ease side effects of chemotherapy and radiation.”
In simple terms, medical experts today highly recommend taking supplements to help patients fight cancer.

How did Gene-Eden-VIR boost the immune system according to the study mentioned above? Gene-Eden-VIR targets the cause of most cancers, not the symptoms. Consider breast cancer as an example. The current belief in the medical community holds that most cases of breast cancer are caused by a mutation in a certain gene. Genes, in general, produce proteins, which are the building blocks of cells. The concentration of proteins is tightly regulated. A mutated or injured gene produces an abnormal concentration of its protein, which may lead to disease.

In 1994, Mark Skolnick, PhD, discovered the BRCA1 gene (BRCA1 is short for BReast CAncer 1). Following the discovery, scientists observed a low level of the BRCA1 protein in breast cancer tissues.

This observation created a lot of excitement. At the time, scientists believed that they were on the verge of finding the cause of breast cancer. The reasoning was that breast cancer patients must have a mutated BRCA1 gene, which would explain the decreased production of the protein, and the development of tumors.

In the United States, 180,000 cases of breast cancer are diagnosed each year. However, only 5% of these cases have a mutated BRCA1 gene. In more than 95% of the breast cancer patients the gene is not mutated.

So here is the mystery. If the gene is not mutated in the great majority of the breast cancer patients, why are the tumors showing a low level of the BRCA1 protein? The BRCA1 gene is not unique. Many normal (perfect shape, non-mutated) genes exhibit a mysterious abnormal (increased or decreased) production of proteins in cancer.

And, breast cancer is only one example.

According to Dr. Hanan Polansky highly acclaimed scientific discovery [1], the cause of most cancers is latent viral DNA that lays hidden in human cells. To survive, the latent viral DNA feeds off the resources it “steals” from the human DNA in these cells, thereby creating a supply shortage for the human genes. The latent viral DNA, which is a genetic parasite, in fact “starves” the human genes, and causes them to behave irregularly, which leads to disease. This effect of the foreign DNA on human genes inspired Dr. Hanan Polansky to call the discovery the “starved” gene phenomenon.

Gene-Eden-VIR was designed to target the most common latent viruses that attack the human body. To learn more about Gene-Eden-VIR please visit:

http://buygeneeden.com/Cancer.php

For more information on the Center for the Biology of Chronic Disease, or to schedule an interview with one of our researchers, please visit http://www.cbcd.net or call 585-250-9999.

Reference:

[1] Polansky H. Microcompetition with foreign DNA and the origin of chronic disease. CBCD publishing. 2003. 543 p.



The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

We invite biologists, virologists, scientists everywhere to download Dr. Polansky’s book, “Microcompetition with Foreign DNA and the Origin of Chronic Disease” here: http://cbcd.net/

The CBCD published the “Purple” book by Dr. Hanan Polansky.

The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.